scholarly journals Colon cancer presenting as pseudo-obstruction during pregnancy – A case report

2017 ◽  
Vol 10 (4) ◽  
pp. 198-200 ◽  
Author(s):  
Reeva Makhijani ◽  
Vicky H Bhagat ◽  
Mariam Fayek

The incidence of colorectal cancer in pregnancy is between 0.002 and 0.008%. Diagnosis is often delayed as symptoms of colorectal cancer can mimic as common complaints of pregnancy. We present the case of a 29-year-old with a history of chronic constipation who presented in the second trimester with abdominal pain, inability to tolerate anything orally and no bowel movement in more than three weeks. Non-contrast MRI at presentation failed to show an obstructing mass. Patient was treated conservatively for presumed pseudo-obstruction secondary to worsening constipation from chronic ondansetron use and pregnancy. After four days without clinical improvement, she had a colonoscopy that revealed a completely obstructing sigmoid mass, which biopsies confirmed was a primary colorectal adenocarcinoma. The patient underwent a total abdominal colectomy. She was referred to medical oncology and began adjuvant chemotherapy consisting of 5-fluorouracil, leucovorin and oxaloplatin four weeks post-operatively.

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Đắc Thao Nguyễn

Tóm tắt Nhân hai trường hợp ung thư đại trực tràng ở người bệnh có thai, chúng tôi xin có một số bàn luận quá trình chẩn đoán, điều trị và điểm lại y văn. Trường hợp 1: Ung thư trực tràng 1/3 trên ở người bệnh có thai tuần 27. Giữ thai đến tuần 32. Phẫu thuật lấy thai, cắt đoạn đại tràng xích ma trực tràng kiểu | Hartmann, xét điều trị bổ trợ sau phẫu thuật. Giai đoạn T4NTM0. Trường hợp 2: Người bệnh thai 14 tuần tắc ruột do u đại tràng trái di căn phúc mạc. Phẫu thuật làm hậu môn nhân tạo + sinh thiết u, đình chỉ thai. Người bệnh không điều trị bổ trợ, còn sống sau mổ (10 tháng). Từ khóa: Ung thư đại trực tràng, thai kì, ung thư trong thai kì Abstract We report a case of patient in the third trimester of pregnancy with rectal cancer, and another case of patient at 14 week of pregnancy with left colon cancer presenting bowel obstruction. Keyword: Colorectal cancer, pregnancy, cancer in pregnancy


2006 ◽  
Vol 66 (S 01) ◽  
Author(s):  
IK Himsl ◽  
MS Lenhard ◽  
F von Koch ◽  
M Wichmann ◽  
A Schulze ◽  
...  

2021 ◽  
pp. 000313482110318
Author(s):  
Thomas K. Kleinschmidt ◽  
Austin Clements ◽  
Mark A. Parker ◽  
Steven D. Scarcliff

Objectives To review the effectiveness of noninvasive multitarget stool DNA testing as a screening test for colorectal cancer. Methods We performed a retrospective review of patients referred to 2 high volume outpatient procedural centers for colonoscopy for positive Cologuard test. Positive findings for colorectal cancer based on pathologic findings and also advanced adenomas were recorded. Positive predictive value (PPV) was assessed. Results Of the 1585 patients evaluated and referred for colonoscopy from January 1, 2018 to November 1, 2019, for ICD-10 codes R19.5 (other fecal abnormalities) and K92.1 (melena), 84 were referred for a positive Cologuard test. Out of the 84, 6 were excluded based on family history of colon cancer in first degree relative or personal history of inflammatory bowel disease. Of the remaining 78 patients, 1 patient (1.3%) had colorectal cancer and 5 (6.4%) had advanced adenomas (>1 cm size, high grade dysplasia or villous). Postive predictive value for colorectal cancer was 1.3% and for precancerous lesions plus colorectal cancer was 7.7%. A total of 53 (68.0%) patients had either totally normal colonoscopy or hyperplastic polyps. Out of the 78 individuals in our study, 70 (89.7%) had normal findings, hyperplastic polyps, or non-advanced adenomas. Conclusions Multitarget stool DNA testing carries an unacceptably low PPV to be utilized as a screening test for colorectal cancer. The study fails to detect both adenomas and colon cancer at a higher rate than screening colonoscopy in selected studies. The advantage of being noninvasive has been noted to increase colorectal cancer screening in otherwise non-compliant Medicare patients.


2015 ◽  
Vol 9 (1) ◽  
Author(s):  
Ziyad Makoshi ◽  
Claire Perrott ◽  
Khadija Al-Khatani ◽  
Fadia Al-Mohaisen

2019 ◽  
Vol 73 (6) ◽  
pp. 355 ◽  
Author(s):  
Kyungjoong Kim ◽  
Myungkwan Ko ◽  
Ho Chan Sim ◽  
Chang Lae Kim ◽  
Yeo Jin Jung ◽  
...  

2004 ◽  
Vol 18 (5) ◽  
pp. 319-320 ◽  
Author(s):  
Victor K Wong ◽  
Eric M Yoshida ◽  
Anthony G Ryan ◽  
Stephen GF Ho ◽  
Baljinder Salh

BACKGROUND:Hereditary nonpolyposis colorectal cancer (HNPCC) currently accounts for between 2% to 6% of all colorectal adenocarcinomas. Controversies exist regarding the current guidelines for colonoscopic screening for colon cancer.CASE REPORT:A case of colon cancer in a young Japanese man with a family history of colon cancer that did not meet the criteria for HNPCC is reported. A malignant pelvic mass discovered shortly before his 20th birthday prompted a colonoscopy. The findings at colonscopy determined that the patient and his family fulfilled the criteria of HNPCC.CONCLUSION:Before finding a pelvic mass metastatic from adenocarcinoma of the ascending colon, this patient was clearly outside of the current guidelines for HNPCC screening. It is suggested that in similar patients, even if they do not fulfill all the criteria for HNPCC, it would be appropriate to consider screening well before the recommended lower age.


2015 ◽  
Vol 87 (2) ◽  
pp. 167
Author(s):  
Yusuke Yagihashi ◽  
Yoshitaka Arakaki

Urethral recurrence arising from a primary colorectal adenocarcinoma is rare. Here, we report a case of urethral recurrence of sigmoid colon cancer, which developed after cysto-prostato-sigmoidectomy for sigmoid colon cancer invading the bladder. The patient underwent urethrectomy successfully and is currently tumor-free. Surgeons who follow patients with colorectal cancer invading the bladder should be aware of this case. The early detection of recurrence improves the chances for disease-free survival.


2012 ◽  
Vol 95 (2) ◽  
pp. 413-419 ◽  
Author(s):  
Eunyoung Cho ◽  
Jung Eun Lee ◽  
Eric B Rimm ◽  
Charles S Fuchs ◽  
Edward L Giovannucci

Sign in / Sign up

Export Citation Format

Share Document